Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunity to tumour antigens.

Geng Li1, Selman A Ali, Stephanie E B McArdle

  • 1School of Biomedical and Natural Sciences, Nottingham Trent University, Clifton Lane, Clifton, Nottingham, NG11 8NS, UK.

Current Pharmaceutical Design
|October 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The homeobox gene, dmbx1a, is required for the development and maintenance of bipolar and photoreceptor cells in the zebrafish retina.

Experimental eye research·2025
Same author

Local Coordination-Dependent CO<sub>2</sub> Reduction Activity of Bimetallic Cu─Al Catalysts for Selective Ethylene/Ethanol Electrosynthesis.

Angewandte Chemie (International ed. in English)·2025
Same author

Resveratrol Attenuates H<sub>2</sub>O<sub>2</sub>-induced Aging and Apoptosis in Mouse Hippocampal Neuron HT22 Cells by Activating Autophagy via the SIRT1/FoxO1 Signaling Pathway.

Molecular neurobiology·2025
Same author

A Protein Interactome-Based Framework Reveals the General Toxicity of Chemicals.

Environmental science & technology·2025
Same author

Investigation of floor blasting for rock burst prevention in high-stress roadway under dynamic loading.

Scientific reports·2025
Same author

Defect engineering-driven enhancement of C<sub>2+</sub> products over FeCN-modified cu for acidic CO<sub>2</sub> electroreduction.

Journal of colloid and interface science·2025

Identifying human tumor antigens is crucial for cancer immunotherapy. This review covers tumor antigen discovery, current status, and applications for enhancing anti-tumor immune responses.

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Numerous human tumor antigens have been identified in the past decade.
  • Tumor antigens are categorized into several types, including tumor-specific shared, tissue-specific differentiation, overexpressed, mutation-derived, viral, and fusion protein antigens.
  • Antigens recognized by the immune system offer potential targets for cancer immunotherapy.

Purpose of the Study:

  • To review the various approaches used for the discovery of tumor antigens.
  • To summarize the current understanding and status of identified tumor antigens.
  • To discuss the potential applications of tumor antigens in cancer treatment strategies.

Main Methods:

  • Literature review of scientific publications on tumor antigen discovery and cancer immunotherapy.

Related Experiment Videos

  • Categorization and analysis of different types of human tumor antigens.
  • Synthesis of information regarding the immunogenicity and therapeutic potential of tumor antigens.

    • Main Results:

    • A wide array of human tumor antigens have been discovered, classified by their origin and characteristics.
    • Most tumor antigens are self-proteins with low immunogenicity, often leading to ineffective immune responses.
    • Challenges remain in inducing and enhancing effective tumor antigen-specific immune responses.

    Conclusions:

    • Effective cancer immunotherapy relies on targeting specific tumor antigens.
    • Further research is needed to overcome the low immunogenicity of self-tumor antigens.
    • Developing strategies to enhance tumor antigen-specific immune responses is critical for advancing cancer treatment.